353 related articles for article (PubMed ID: 20536980)
1. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
Brackmann HH; Gormsen J
Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
[No Abstract] [Full Text] [Related]
2. Commentary on Brackmann and Gormsen (Lancet 1977; ii: 933): Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
Lee CA
Haemophilia; 2010 May; 16(102):4-5. PubMed ID: 20536981
[No Abstract] [Full Text] [Related]
3. Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
Brackmann HH; Gormsen J
Lancet; 1977 Oct; 2(8044):933. PubMed ID: 72276
[No Abstract] [Full Text] [Related]
4. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
5. [Prophylaxis in patients with haemophilia complicated by inhibitors].
Paweł Ł
Pol Merkur Lekarski; 2011 Mar; 30(177):211-4. PubMed ID: 21545000
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of hemorrhage in patients with hemophilia].
Pliushch OP; Rutberg RA; Zakhrova NS; Shefter LI
Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):11-3. PubMed ID: 1273055
[No Abstract] [Full Text] [Related]
7. Experience with prophylaxis in Sweden.
Nilsson IM
Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
[No Abstract] [Full Text] [Related]
8. [New viewpoints in the treatment of hemophilia].
Göbel U
Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
[No Abstract] [Full Text] [Related]
9. Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
Guérois C; Laurian Y; Rothschild C; Parquet-Gernez A; Duclos AM; Négrier C; Vicariot M; Fimbel B; Fressinaud E; Fiks-Sigaud M
Thromb Haemost; 1995 Feb; 73(2):215-8. PubMed ID: 7792732
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
Levine PH
N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
[No Abstract] [Full Text] [Related]
11. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
Thornburg CD; Pipe SW
Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
[No Abstract] [Full Text] [Related]
12. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
Duckert F; Müller G; Meili EO
Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
[No Abstract] [Full Text] [Related]
13. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
Bona RD; Weinstein RA; Weisman SJ; Bartolomeo A; Rickles FR
Am J Hematol; 1989 Sep; 32(1):8-13. PubMed ID: 2502914
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
Sultan Y; Brouet JC
Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of handicapping hemorrhagic complications in severe and moderate hemophilia].
Landbeck G; Kurme A
Med Welt; 1973 May; 24(19):763-8. PubMed ID: 4720575
[No Abstract] [Full Text] [Related]
16. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
[TBL] [Abstract][Full Text] [Related]
17. Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated.
Scheibel E; Ingerslev J; Dalsgaard-Nielsen J; Stenbjerg S; Knudsen JB
Thromb Haemost; 1987 Dec; 58(4):1049-52. PubMed ID: 3127918
[TBL] [Abstract][Full Text] [Related]
18. [Substitution treatment in hemophilia. Critical measures and complications].
Schimpf K
Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
[No Abstract] [Full Text] [Related]
19. Prophylaxis in haemophilic children.
Liesner RJ
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S7-10. PubMed ID: 9351529
[TBL] [Abstract][Full Text] [Related]
20. Delivery of treatment for haemophilia.
Haemophilia; 2003 Jul; 9(4):403-4. PubMed ID: 12828676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
